The human gut bacterial genotoxin colibactin alkylates DNA

Abstract
Certain Escherichia coli strains residing in the human gut produce colibactin, a small-molecule genotoxin implicated in colorectal cancer pathogenesis. However, colibactin’s chemical structure and the molecular mechanism underlying its genotoxic effects have remained unknown for more than a decade. Here we combine an untargeted DNA adductomics approach with chemical synthesis to identify and characterize a covalent DNA modification from human cell lines treated with colibactin-producing E. coli. Our data establish that colibactin alkylates DNA with an unusual electrophilic cyclopropane. We show that this metabolite is formed in mice colonized by colibactin-producing E. coli and is likely derived from an initially formed, unstable colibactin-DNA adduct. Our findings reveal a potential biomarker for colibactin exposure and provide mechanistic insights into how a gut microbe may contribute to colorectal carcinogenesis.
Funding Information
  • David and Lucile Packard Foundation (2013-39267)
  • American Cancer Society (PF-16-122-01-CDD)
  • National Cancer Institute (5R01CA208834-02)
  • National Cancer Institute (R50-CA211256)
  • National Cancer Institute (CA-77598)
  • Damon Runyon Cancer Research Foundation (27-14)
  • National Institute of Environmental Health Sciences (R01 ES022872)
  • Damon Runyon Cancer Research Foundation (DRG-2205-14)
  • National Institute of Environmental Health Sciences (R44 ES024698)
  • National Institute of Environmental Health Sciences (P30 ES002109)
  • National Cancer Institute (R01 CA154426)